LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $511,837 | +4.7% | 8,542 | +25.9% | 0.00% | – |
| Q2 2023 | $489,054 | +7.8% | 6,783 | +10.0% | 0.00% | – |
| Q1 2023 | $453,792 | +10.7% | 6,169 | +0.5% | 0.00% | – |
| Q4 2022 | $410,018 | -21.1% | 6,138 | +1.7% | 0.00% | – |
| Q3 2022 | $519,674 | -5.0% | 6,035 | -1.5% | 0.00% | – |
| Q2 2022 | $546,919 | -22.3% | 6,130 | -2.0% | 0.00% | – |
| Q1 2022 | $703,625 | -40.5% | 6,255 | -18.3% | 0.00% | -100.0% |
| Q4 2021 | $1,182,000 | +7.4% | 7,654 | -3.2% | 0.00% | 0.0% |
| Q3 2021 | $1,101,000 | -68.2% | 7,904 | -70.1% | 0.00% | -66.7% |
| Q2 2021 | $3,466,000 | -14.1% | 26,417 | -0.2% | 0.00% | -25.0% |
| Q1 2021 | $4,036,000 | -74.0% | 26,472 | -83.1% | 0.00% | -71.4% |
| Q4 2020 | $15,545,000 | +24.8% | 156,309 | +19.6% | 0.01% | +7.7% |
| Q3 2020 | $12,454,000 | -11.5% | 130,660 | +5.0% | 0.01% | 0.0% |
| Q2 2020 | $14,067,000 | +49.4% | 124,462 | -3.9% | 0.01% | +30.0% |
| Q1 2020 | $9,418,000 | -76.6% | 129,499 | -66.5% | 0.01% | -76.2% |
| Q4 2019 | $40,290,000 | +5.3% | 386,331 | -0.1% | 0.04% | -2.3% |
| Q3 2019 | $38,254,000 | -27.1% | 386,598 | -15.9% | 0.04% | -29.5% |
| Q2 2019 | $52,474,000 | -25.1% | 459,694 | -17.5% | 0.06% | -19.7% |
| Q1 2019 | $70,085,000 | +27.6% | 557,512 | +37.7% | 0.08% | +10.1% |
| Q4 2018 | $54,940,000 | -41.2% | 404,863 | +18.9% | 0.07% | -30.3% |
| Q3 2018 | $93,454,000 | +31.8% | 340,463 | -0.6% | 0.10% | +28.6% |
| Q2 2018 | $70,928,000 | +2733.7% | 342,369 | +2159.3% | 0.08% | +2466.7% |
| Q1 2018 | $2,503,000 | +17.3% | 15,154 | -2.8% | 0.00% | +50.0% |
| Q4 2017 | $2,134,000 | +1.6% | 15,588 | +1.0% | 0.00% | -33.3% |
| Q3 2017 | $2,100,000 | +10.7% | 15,429 | -1.3% | 0.00% | +50.0% |
| Q2 2017 | $1,897,000 | +21.6% | 15,630 | +6.1% | 0.00% | 0.0% |
| Q1 2017 | $1,560,000 | +18.4% | 14,734 | +13.6% | 0.00% | 0.0% |
| Q4 2016 | $1,318,000 | -0.2% | 12,969 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,320,000 | -13.8% | 12,933 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $1,532,000 | +25.1% | 12,847 | +10.1% | 0.00% | +100.0% |
| Q1 2016 | $1,225,000 | -1.4% | 11,669 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,242,000 | +27.8% | 11,454 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $972,000 | -12.7% | 11,345 | +2.8% | 0.00% | 0.0% |
| Q2 2015 | $1,113,000 | +10.6% | 11,035 | -15.5% | 0.00% | 0.0% |
| Q1 2015 | $1,006,000 | +46.2% | 13,052 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $688,000 | +8.5% | 12,946 | -4.1% | 0.00% | 0.0% |
| Q3 2014 | $634,000 | -83.2% | 13,500 | -77.7% | 0.00% | -83.3% |
| Q2 2014 | $3,777,000 | +314.6% | 60,647 | +347.4% | 0.01% | +500.0% |
| Q1 2014 | $911,000 | +27.1% | 13,555 | -0.6% | 0.00% | 0.0% |
| Q4 2013 | $717,000 | +20.7% | 13,640 | -0.7% | 0.00% | 0.0% |
| Q3 2013 | $594,000 | +14.5% | 13,735 | -1.0% | 0.00% | 0.0% |
| Q2 2013 | $519,000 | – | 13,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |